Quarterly Results

MPS PHARMAA LTD.

NSE : NABSE : 531686ISIN CODE : INE537C01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.210 (0 %)
PREV CLOSE ( ) 3.21
OPEN PRICE ( ) 3.21
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2601
TODAY'S LOW / HIGH ( )3.21 3.21
52 WK LOW / HIGH ( ) 2.13.21
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
NA
NA
NA
NA
Total Expenditure
1.84
2.11
1.92
3.1
PBIDT (Excl OI)
-1.84
-2.11
-1.92
-3.1
Other Income
NA
0.58
0.34
0.23
Operating Profit
-1.84
-1.53
-1.58
-2.87
Interest
0.00
0.00
NA
0.00
Exceptional Items
NA
NA
NA
NA
PBDT
-1.84
-1.53
-1.58
-2.87
Depreciation
0.37
0.37
0.37
0.36
Profit Before Tax
-2.21
-1.9
-1.95
-3.23
Tax
-0.06
-0.06
-0.06
-0.07
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-2.15
-1.84
-1.89
-3.16
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-2.15
-1.84
-1.89
-3.16
Equity Capital
191.11
191.11
191.11
191.14
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
-0.11
-0.09
-0.09
-0.16
Calculated EPS (Annualised)
-0.45
-0.38
-0.39
-0.66
No of Public Share Holdings
12251919
12251919
12251919
12251919
% of Public Share Holdings
64.11
64.11
64.11
64.11
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
NA
NA
NA
NA
PBIDTM%
NA
NA
NA
NA
PBDTM%
NA
NA
NA
NA
PBTM%
NA
NA
NA
NA
PATM%
NA
NA
NA
NA
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.